Evidence map›Paper›PMID 29636418›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Spider toxin inhibits gating pore currents underlying periodic paralysis.

Roope Männikkö, Zakhar O Shenkarev, Michael G Thor, Antonina A Berkut, Mikhail Yu Myshkin, Alexander S Paramonov, Dmitrii S Kulbatskii, Dmitry A Kuzmin, Marisol Sampedro Castañeda, Louise King and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. A structural atlas of druggable sites on NaChannels (Austin, Tex.) · 2024
    Review
  5. Article
  6. Design of Ultrapotent Genetically Encoded Inhibitors of Kv4.2 for Gating Neural Plasticity.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  7. Periodic paralysis.Handbook of clinical neurology · 2024
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Voltage-Gated CaFrontiers in synaptic neuroscience · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. NaScientific reports · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 3 countries.

Roope MännikköMRC Centre for Neuromuscular Diseases, Department of Molecular Neuroscience, UCL Institute of Neurology, WC1N 3BG London, United Kingdom; r.mannikko@ucl.ac.uk avas@ibch.ru.
Zakhar O ShenkarevShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
Michael G ThorMRC Centre for Neuromuscular Diseases, Department of Molecular Neuroscience, UCL Institute of Neurology, WC1N 3BG London, United Kingdom.
Antonina A BerkutShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
Mikhail Yu MyshkinShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
Alexander S ParamonovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
Dmitrii S KulbatskiiShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
Dmitry A KuzminDepartment of Clinical and Experimental Epilepsy, UCL Institute of Neurology, WC1N 3BG London, United Kingdom.
Marisol Sampedro CastañedaMRC Centre for Neuromuscular Diseases, Department of Molecular Neuroscience, UCL Institute of Neurology, WC1N 3BG London, United Kingdom.
Louise KingMRC Centre for Neuromuscular Diseases, Department of Molecular Neuroscience, UCL Institute of Neurology, WC1N 3BG London, United Kingdom.
Emma R WilsonMRC Centre for Neuromuscular Diseases, Department of Molecular Neuroscience, UCL Institute of Neurology, WC1N 3BG London, United Kingdom.
Ekaterina N LyukmanovaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
Mikhail P KirpichnikovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
Stephanie SchorgeDepartment of Clinical and Experimental Epilepsy, UCL Institute of Neurology, WC1N 3BG London, United Kingdom.
Frank BosmansDepartment of Physiology, Johns Hopkins University School of Medicine; Baltimore, MD 21205.
Michael G HannaMRC Centre for Neuromuscular Diseases, Department of Molecular Neuroscience, UCL Institute of Neurology, WC1N 3BG London, United Kingdom.
Dimitri M KullmannDepartment of Clinical and Experimental Epilepsy, UCL Institute of Neurology, WC1N 3BG London, United Kingdom.
Alexander A VassilevskiShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia; r.mannikko@ucl.ac.uk avas@ibch.ru.ORCID 0000-0002-1359-0076
University College London · GBMoscow Institute of Physics and Technology · RULomonosov Moscow State University · RUInstitute of Bioorganic Chemistry · RUJohns Hopkins University · US

Funding

Voltage-gated sodium channel modulation by Beta1 and Beta4 (R01NS091352)R01NS091352 · NINDS · JOHNS HOPKINS UNIVERSITY · PI BOSMANS, FRANK GERT WERNER · 2015 to 2019
$1.3M
Medical Research Council G0601943Medical Research Council G116/147Medical Research Council MR/K000608/1Medical Research Council MR/L01095X/1Medical Research Council MR/M006948/1NINDS NIH HHS R01 NS091352Wellcome Trust 212285/Z/18/Z
6 · The paper itself

Abstract

Gating pore currents through the voltage-sensing domains (VSDs) of the skeletal muscle voltage-gated sodium channel Na

Indexed as

Mutation, MissenseProtein Structure, SecondaryAmino Acid SubstitutionAnimalsFemaleHEK293 CellsHumansIon Channel GatingNAV1.4 Voltage-Gated Sodium ChannelNeurotoxinsParalysis, Hyperkalemic PeriodicSpider VenomsXenopus laevisNAV1.4 Voltage-Gated Sodium ChannelNeurotoxinsSCN4A protein, humanSpider Venomschannelopathygating modifierhypokalemic periodic paralysisneurotoxinsodium channel

Identifiers

PMID29636418
PMCPMC5924911
OpenAlexW2797829690

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.